ZENAS BIOPHARMA, INC. — Balance Sheet Charts
10 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+3.7% +$14M
$384M
Current Assets↓-1.3% -$5M
$351M
Cash & Equivalents↓-65.4% -$209M
$111M
ST Investments↑+649.6% +$202M
$233M
Net PPE↓-81.6% -$151K
$34K
Total Liabilities↑+146.0% +$84M
$141M
Current Liabilities↑+9.4% +$5M
$63M
Account Payables↓-58.5% -$10M
$7M
Long-Term Debt
$79M
Stockholders Equity↓-22.5% -$70M
$242M
Retained Earnings↓-97.5% -$378M
$-765M
Operating Lease ROU Asset↑+34.9% +$350K
$1M
Operating Lease Liability↑+32.2% +$323K
$1M